6
defendants applied toxic chemicals after they ran out of the non-toxic product. Plaintiff
sued, alleging fraud, negligence, trespass and other claims. At trial, plaintiff proffered
the testimony of Dr. William Rea, who diagnosed plaintiff with “chemical sensitivity”
and related conditions, and concluded that exposure to defendant’s pesticides
exacerbated those conditions. The trial court excluded Dr. Rea’s testimony, concluding
that it did not qualify for admissibility under State v. O’Key, 321 Or 285 (1995). The
court noted that the American Medical Association (AMA) and other professional
organizations do not recognize “chemical sensitivity” as a valid medical diagnosis, and
virtually every court that previously addressed the issue refused to allow Dr. Rea and his
associates testify as experts on “chemical sensitivity.” 222 Or App at 450-51. The Court
of Appeals reversed. The court first noted that, when all the evidence was considered,
“the most that can be said is that there is a controversy in the medical community about
whether chemical sensitivity…is a valid diagnosis.” Id. at 447. The court concluded
that, “the competing views between the two schools of scientific thought did not
authorize the trial court in its gatekeeping function to exclude plaintiff’s
evidence…because each school of thought reaches a conclusion that is ‘biologically
plausible[.]’” Id. at 450 (citing Marcum v. Adventist Health System/West, 345 Or 237,
248-49 (2008).
The fact that no other court had allowed expert testimony on “chemical
sensitivity” did not matter, the court explained, because under Oregon law, “the proper
inquiry is not whether…chemical sensitivity is a "valid" diagnosis or is recognized by
other jurisdictions; rather, we must, on the record in this case, ‘decide whether
truthfinding is better served by admission or exclusion.’” Id. at 451 (quoting O'Key, 321
Or at 299). The court stated that, regardless of what other courts have done, it has “an
obligation to independently construe the relevant provisions of the Oregon Evidence
Code.” Id. The court noted “the Oregon legislature's strong policy to aid the trier of fact
to understand the evidence presented at trial in the context of the parties' theory of the
case” and concluded that “the legislature intended controversial evidence like Rea's
testimony to be presented to the jury.” Id. at 451-52. “In Oregon, we trust juries to be
able to find the truth in the classic ‘battle of the experts.’" Id. at 452.
Blake v. Cell Tech International, Inc., 228 Or App 388 (2009)
The plaintiff in Blake brought a wrongful death action against companies that
manufacture and distribute a dietary supplement called Blue Green Algae. Plaintiff
alleged that decedent consumed the dietary supplement, which “contained toxins called
‘microsystins,’ and those microcystins caused decedent’s liver and renal (kidney)
failure,” resulting in her death at the age of 34. 228 Or App at 390. Plaintiff called an
expert witness, Dr. Dietrich, to testify “regarding the immunohistochemical (IHC) tests
he performed to detect microcystin toxins in decedent’s liver and kidneys.” The trial